Interleukin-1 beta (IL-1β) as adjuvant enhances the immune effects of Aeromonas veronii inactivated vaccine in largemouth bass ( Micropterus salmoides )

Ze-Sheng Zhang,Heng-Chu Ren,Xie Gu,Qian-Rong Liang,Hui Fei,Yu-Hong Yang,Shun Yang,Liang-Yin He,Li-Li Liu
DOI: https://doi.org/10.1016/j.ijbiomac.2024.133135
IF: 8.2
2024-06-16
International Journal of Biological Macromolecules
Abstract:Largemouth bass ( Micropterus salmoides ) has emerged as a significant economic fish species, with a rise in Aeromonas veronii infections in farming. However, research on adjuvants for vaccines against A. veronii in largemouth bass remains scarce. In present study, recombinant largemouth bass IL-1β (LbIL-1β) was expressed to explore its adjuvant effect on the A. veronii inactivated vaccine. Following vaccination with recombinant LbIL-1β (rLbIL-1β) and the inactivated A. veronii , higher serum SOD levels and lysozyme activities were observed in largemouth bass from inactivated A. veronii + rLbIL-1β vaccinated group. Furthermore, it was discovered that rLbIL-1β was able to boost the serum-specific antibody levels induced by the inactivated A. veronii . The qRT-PCR analysis revealed that rLbIL-1β also enhanced the expression of IgM, CD4, and MHC II in largemouth bass triggered by the inactivated A. veronii . After challenged with live A. veronii , the outcomes demonstrated that the relative percentage survival (RPS) for largemouth bass resulting from the inactivated A. veronii in combination with rLbIL-1β was 76.67 %, surpassing the RPS of 60 % in the inactivated A. veronii group. Collectively, these findings indicate that rLbIL-1β enhances the protective effect of the A. veronii inactivated vaccine on largemouth bass, showcasing potential as an adjuvant for further development.
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?